Structural instability of plasmid biopharmaceuticals: challenges and implications.

/0 Comments/in /by

Oliveira PH, Prather KJones, Prazeres DMF, Monteiro GA.  2009.  Structural instability of plasmid biopharmaceuticals: challenges and implications. Trends Biotechnol. 27(9):503-11. Google Scholar PubMed

You might also like
Adaptive mutations that prevent crosstalk enable the expansion of paralogous signaling protein families.
Precise manipulation of chromosomes in vivo enables genome-wide codon replacement.
Analysis of DNA repeats in bacterial plasmids reveals the potential for recurrent instability events.
Genome engineering.
A dynamic complex of signaling proteins uses polar localization to regulate cell-fate asymmetry in Caulobacter crescentus.
Crystal structure of Cas9 in complex with guide RNA and target DNA.
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.
Inhibiting Plasmodium falciparum growth and heme detoxification pathway using heme-binding DNA aptamers.